Asensus Surgical Announces Machine Learning and Cloud Infrastructure Collaboration with Google Cloud to Advance Performance-Guided Surgery
February 14 2023 - 5:55AM
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device
company that is digitizing the interface between the surgeon and
the patient, today announced a multi-year collaboration with Google
Cloud to integrate Google Cloud’s secure cloud data architecture
and machine learning (ML) technologies to further expand the
capabilities of the Asensus Surgical’s Performance-Guided Surgery™
(PGS) framework enabled through the Intelligent Surgical Unit ™
(ISU™).
Performance-Guided Surgery can help surgeons
perform procedures more accurately and efficiently, and ultimately
help surgeons avoid complications and improve patient outcomes.
“We are thrilled to be collaborating with Google Cloud to
realize and scale our Performance Guidance Surgery capabilities, by
leveraging the data collected by our state-of-the-art ISU
technology in conjunction with Google Cloud’s leading machine
learning technologies and cloud architecture,” said Anthony
Fernando, Asensus Surgical President and CEO. “For several years,
we have been pioneering digital surgical capabilities to provide
surgeons with novel, real-time intraoperative digital tools and
clinical intelligence. This collaboration to better capture
clinical performance data and apply augmented intelligence
capabilities to provide clinical insight, will ultimately drive
consistently superior outcomes for patients.”
The ISU is a real-time intraoperative surgical image analytics
platform that leverages augmented intelligence to help reduce
surgical variability and provides tools to reduce a surgeon’s
cognitive fatigue while collecting clinical data related to the
surgical procedure. Asensus will enable customer access portals and
performance dashboards for surgeons and hospitals, and Google
Cloud’s secure cloud data architecture will capture this data.
Asensus will use Google Cloud’s machine learning technologies to
analyze the data and discern clinical intelligence that can be
utilized by surgeons and hospitals in addition to continuously
improving the software in the ISU to provide better intra-operative
clinical insight.
“Asensus’ expertise in real-time intraoperative tools combined
with our expertise in secure data-capture and machine learning will
give surgeons advanced insights to help them in their important
work,” said Aashima Gupta, Global Director of Healthcare for Google
Cloud. “We are bringing our shared commitment to developing
powerful tools for surgeons and healthcare providers around the
world, ultimately enabling them to offer more effective,
digitally-enabled care to patients worldwide."
Additional details on this partnership will be provided at
Asensus Surgical’s previously announced investor day that will take
place at 11:30 am on Tuesday, February 21, 2023 in New York City.
Additional details about this event can be found on the Company’s
website at https://ir.asensus.com/events-and-presentations.
About Asensus Surgical, Inc.
Asensus Surgical, Inc. is digitizing the interface between the
surgeon and patient to pioneer a new era of Performance-Guided
Surgery by unlocking clinical intelligence for surgeons to enable
consistently superior outcomes and a new standard of surgery. This
builds upon the foundation of Digital Laparoscopy with the
Senhance® Surgical System powered by the Intelligent Surgical Unit
(ISU) to increase surgeon control and reduce surgical variability.
With the addition of machine vision, augmented intelligence, and
deep learning capabilities throughout the surgical experience, we
intend to holistically address the current clinical, cognitive and
economic shortcomings that drive surgical outcomes and value-based
healthcare. Learn more about Performance-Guided Surgery and Digital
Laparoscopy with the Senhance Surgical System here:
www.senhance.com. Now available for sale in the US, EU, Japan,
Russia, and select other countries. For a complete list of
indications for use, visit: www.senhance.com/indications. For more
information, visit www.asensus.com.
Follow Asensus
Email Alerts: https://ir.asensus.com/email-alerts
LinkedIn:
https://www.linkedin.com/company/asensus-surgical-inc
Twitter: https://twitter.com/AsensusSurgical
YouTube: https://www.youtube.com/c/transenterix
Vimeo: https://vimeo.com/asxc
TikTok: https://www.tiktok.com/@asensus_surgical
Forward-Looking StatementsThis press release
includes statements relating to Asensus Surgical’s announcement of
its machine learning and cloud infrastructure collaboration with
Google Cloud to advance Performance-Guided Surgery. These
statements and other statements regarding our future plans and
goals constitute "forward looking statements" within the meaning of
Section 27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Act of 1934, and are intended to qualify for
the safe harbor from liability established by the Private
Securities Litigation Reform Act of 1995. Such statements are
subject to risks and uncertainties that are often difficult to
predict, are beyond our control and which may cause results to
differ materially from expectations and include whether the
collaboration between Asensus Surgical and Google Cloud will be
successful and whether the collaboration between Asensus Surgical
and Google Cloud will better capture clinical performance data and
apply Augmented Intelligence capabilities to provide clinical
insight which will ultimately drive consistently superior outcomes
for patients. For a discussion of the risks and uncertainties
associated with the Company’s business, please review our filings
with the Securities and Exchange Commission (SEC), including our
Annual Report on Form 10-K for the year ended December 31, 2021,
filed with the SEC on February 28, 2022 and our other filings we
make with the SEC. You are cautioned not to place undue reliance on
these forward looking statements, which are based on our
expectations as of the date of this press release and speak only as
of the origination date of this press release. We undertake no
obligation to publicly update or revise any forward-looking
statement, whether as a result of new information, future events or
otherwise.
INVESTOR CONTACT:
Mark Klausner or Mike Vallie, 443-213-0499
invest@asensus.com
MEDIA CONTACT:
Isabella Rodriguez, 708-833-1572
CG Life
irodriguez@cglife.com
Asensus Surgical (AMEX:ASXC)
Historical Stock Chart
From Apr 2024 to May 2024
Asensus Surgical (AMEX:ASXC)
Historical Stock Chart
From May 2023 to May 2024